PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-02-17

Date Title Company
17-Feb-2025 Prosmile Completes Acquisition of Neptune Dental Located in New Jersey AccessWire
17-Feb-2025 Global Photodynamic Therapy (PDT) Devices Market: A Look at the 9% CAGR Growth Through 2030 Medi-Tech Insights
17-Feb-2025 Home Healthcare Market Trends, Insights, and Future Projections 2024-2035 Market Business Insights
17-Feb-2025 Digital Pathology Market: Trends, Growth, and Forecast (2023-2030) Market Reports
17-Feb-2025 Boomerang Ventures Leads Seed Round in Lizzy Care to Advance AI-Driven At-Home Dementia and Memory Care Solutions AccessWire
17-Feb-2025 Medical Device Outsourcing Market Size & Share | Growth Analysis 2035 Market Business Insights
17-Feb-2025 Lab Automation Market [2024-2035]: Trends, Competitive Landscape, and Future Outlook Market Reports
17-Feb-2025 Microfluidics Market Analysis (2024-2035): Trends, Innovations, and Future Outlook Vantage Market Research
17-Feb-2025 Clinical Workflow Solutions Market Overview (2024-2035) Market Reports
17-Feb-2025 AI in Healthcare Market Innovations, Investments and Future Outlook Cervicorn Consulting
17-Feb-2025 Medical Tourism Market: Growth, Trends, and Future Outlook (2024-2035) Market Reports
17-Feb-2025 £2m hMPV characterisation study contract hVIVO plc
17-Feb-2025 Kromek receives $25.0m under agreement with Siemens Healthineers Kromek Group plc
17-Feb-2025 NEW ‘SUPER TEST’ FOR PROSTATE CANCER DEVELOPED IN THE UK EDX Medical Group
17-Feb-2025 ASTCT Announces David L. Porter, MD as 2025-2026 President AccessWire
17-Feb-2025 The Dermatology Devices Market: Trends, Innovations, and Future Outlook (2024-2035) Vantage Market Research
17-Feb-2025 Sartorius Stedim Biotech releases Universal Registration Document 2024 Sartorius Stedim Biotech SA
17-Feb-2025 Formycon AG informs about recent developments in various biosimilar projects and invites to conference call Formycon AG
17-Feb-2025 Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins AccessWire
17-Feb-2025 Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201 Formycon AG